MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹139 Cr | ₹93 Cr | ₹21 Cr | ₹176 Cr | ₹94 Cr |
What is the latest Net Cash Inflow / Outflow ratio of MARKSANS PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹139 Cr |
| Mar2025 | ₹93 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹176 Cr |
| Mar2022 | ₹94 Cr |
How is Net Cash Inflow / Outflow of MARKSANS PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹139 Cr | 50.18 | |
| Mar2025 | ₹93 Cr | 343.90 | |
| Mar2024 | ₹21 Cr | -88.16 | |
| Mar2023 | ₹176 Cr | 86.52 | |
| Mar2022 | ₹94 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹13,788.6 Cr | -3.4% | -1.2% | 59.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -3.4% |
-1.2% |
59.6% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses